Neoantigen Dendritic Cell Vaccine Therapy
What is Neoantigen Dendritic Cell Vaccine Therapy?
Neoantigen Dendritic Cell Vaccine Therapy is like a "special training program that teaches the body to fight cancer."
Neoantigen Dendritic Cell Vaccine Therapy is a personalized cancer treatment method. This therapy activates the patient's immune system to recognize and attack cancer cells. First, a sample is taken from the patient's blood to analyze the genes of the cancer cells and identify unique mutation markers called neoantigens. Next, dendritic cells, which act as "commanders" in the immune system, are extracted from the patient's blood. In the laboratory, these dendritic cells are combined with the neoantigens to learn to recognize the cancer cells' characteristics. The trained dendritic cells are then made into a vaccine and injected back into the patient's body. Once inside, these dendritic cells activate the immune system, teaching other immune cells how to recognize and attack cancer cells carrying these neoantigens. Through this personalized immune system training, the patient's body can more effectively fight cancer, reduce the impact on healthy cells, and improve the treatment's targeting and effectiveness.
Reasons to Choose Neoantigen Dendritic Cell Vaccine Therapy
-
Personalized Treatment: Each person's cancer is unique. Neoantigen Dendritic Cell Vaccine Therapy customizes the treatment based on the patient's specific cancer cell characteristics, providing targeted treatment and enhancing efficacy.
-
Enhanced Immune System Recognition: This therapy trains the patient's immune system to more effectively recognize and attack cancer cells, boosting the body's natural defense mechanisms.
-
Fewer Side Effects: Compared to traditional chemotherapy and radiation therapy, this therapy generally has fewer side effects because it primarily targets cancer cells rather than healthy cells, resulting in a better quality of life for the patient.
-
Durable Immune Response: Dendritic cells can create long-lasting immune memory, enabling the immune system to quickly respond even if the cancer recurs, offering long-term protection.
-
New Treatment Hope: For patients who have not responded well to traditional treatments, Neoantigen Dendritic Cell Vaccine Therapy offers a new treatment option, providing better future control of the disease.
The Process of Neoantigen Dendritic Cell Vaccine Therapy
-
Online Consultation: Patients first send all their medical records and examination reports to our hospital, which will be reviewed by overseas doctors. A video consultation with the doctor will then be arranged.
-
Blood Extraction: Our hospital will assist in arranging for the patient to visit a local clinic for the blood extraction process.
-
Dendritic Cell Extraction: Dendritic cells, which help activate the immune system, are extracted from the patient's blood.
-
Cultivation: In the laboratory, the identified neoantigens are added to the dendritic cells, enabling them to recognize and remember the characteristics of these cancer cells.
-
Reinfusion of Dendritic Cells: The modified dendritic cells are reinfused into the patient's body.
Advantages of "HKLSC" in Neoantigen Dendritic Cell Vaccine Therapy
The Only Global Patented Technology
We are the only globally patented provider dedicated to offering the most advanced Neoantigen Dendritic Cell Vaccine Therapy. This highly personalized cancer treatment method aims to use the patient's immune system to recognize and attack cancer cells. Its excellent targeting capability ensures that the treatment precision reaches 100%.
Innovative Breakthrough in Traditional Methods
Traditionally, identifying neoantigens (Neoantigen) required extracting samples from the patient's tumor. However, our collaborative research with the University of Tokyo Medical Institute has developed a new method that only requires drawing the patient's blood to find neoantigens. This innovative breakthrough not only simplifies the operation process but also reduces the patient's pain and discomfort.
